Samuel earned his B.S. in Biomedical Engineering from the University of Wisconsin-Madison in 2020. During his time at Wisconsin, he worked in the Microtechnology Core in association with the MMB lab in order to design, fabricate, and test microfluidic devices for a wide range of research purposes. He also worked in Dr. Megan McClean’s lab studying the Transkingdom conjugation between various bacteria and yeast strains. During the summer of 2019, Samuel worked at the Wake Forest Institute for Regenerative Medicine in Dr. Aleksander Skardal’s lab. He developed a method to bioprint patient derived Multiple Myeloma organoids in order to assess effective drug therapies. Samuel is currently a PhD student in Dr. Adam Feinberg’s lab at Carnegie Mellon University, where he is interested in conducting research on organoids and 3D bioprinting.